EIKN logo

Eikon Therapeutics, Inc. Common Stock

EIKN
Healthcare|Biotechnology|US
$5.90
+0.06 (+1.03%)
Tangible Book / Share
$8.62
Cash / Share
$9.82

Financials

Financial Snapshot

Market Cap
$319.4M
Enterprise Value
$428.6M
Revenue (TTM)
$0.00
Net Income (TTM)
-$322.2M
Cash & Investments
$531.6M
Net Cash
$279.4M
Free Cash Flow (TTM)
-$259.2M
Operating CF (TTM)
-$256.0M
Debt/Equity
0.54

Cash Runway & Burn Rate

Cash on Hand
$531.6M
Quarterly Burn
$64.0M
Monthly Burn
$21.3M
Est. Runway
~8.3 quarters
MetricTrend2025TTM
Cash & Investments
$336.0M$531.6M
Operating Cash Flow
-$188.5M-$256.0M
Free Cash Flow
-$235.3M-$259.2M
Capital Expenditure
-$46.7M-$3.2M
Financing Cash Flow
$352.1M$350.6M

R&D Spending

R&D (TTM)
$270.0M
R&D Intensity
—
R&D Growth vs Prior
+7.9%
MetricTrend2025TTM
Revenue
$0.00$0.00
R&D Expense
$250.3M$270.0M
SG&A
$88.6M$58.5M

Income Statement

MetricTrend2025TTM
Revenue
$0.00$0.00
Cost of Revenue
$24.2M$15.2M
Gross Profit
-$24.2M-$15.2M
R&D
$250.3M$270.0M
SG&A
$88.6M$58.5M
Operating Income
-$338.9M-$338.6M
Interest Expense
$837.0K$0.00
Pretax Income
-$324.2M-$322.2M
Net Income
-$324.2M-$322.2M
EPS (Diluted)
-6.16-4.63
EBITDA
-$299.2M-$297.1M
Shares Out. (M)
54.1454.15

Balance Sheet

MetricTrend2025TTM
Cash & Equivalents
$104.9M$143.0M
Short-Term Investments
$231.1M$388.6M
Total Current Assets
$348.9M$547.0M
Total Assets
$594.7M$779.6M
Total Current Liabilities
$55.0M$55.3M
Long-Term Debt
$0.00$0.00
Total Liabilities
$1.47B$313.1M
Stockholders' Equity
-$879.0M$466.5M
Retained Earnings
-$920.5M-$1.09B

Cash Flow Statement

MetricTrend2025TTM
Operating Cash Flow
-$188.5M-$256.0M
Capital Expenditure
-$46.7M-$3.2M
Free Cash Flow
-$235.3M-$259.2M
Investing Cash Flow
-$181.3M-$88.4M
Financing Cash Flow
$352.1M$350.6M
Issuance of Stock
$1.9M$350.7M
Repurchase of Stock
$0.00$0.00
Net Debt Issuance
$0.00$0.00
Stock Based Comp.
$18.0M$7.9M
Net Change in Cash
-$17.8M$6.1M

Dilution Tracker

Shares Outstanding
54M
5-Year Share Growth
+0.0%
Stock Issuance (TTM)
$350.7M
MetricTrend2025TTM
Shares Out. (M)
54.1454.15
Change vs Prior %—0.0%
Stock Issuance
$1.9M$350.7M
Stock Repurchase
$0.00$0.00
Stock Based Comp.
$18.0M$7.9M

Margins & Profitability

MetricTrend2025TTM
ROE %
36.9%193.4%
ROA %
-54.5%-41.3%
ROIC %
-61.7%-46.2%

Valuation

P/E (TTM)At Loss
P/S0.00
P/B0.68
EV/EBITDAAt Loss
EV/Revenue0.00
P/FCFAt Loss

Intrinsic Value Models (per share)

Tangible Book / Share
$8.62
Net Current Assets / Share
$4.32
Graham Net-Net
$4.04
Cash / Share
$9.82
MetricTrend2025TTM
P/E Ratio
-2.44-1.27
P/S Ratio
0.000.00
P/B Ratio
-0.920.68
EV/EBITDA
-3.22-1.44
EV/Revenue
0.000.00

Analyst Estimates & Quality

Forward Estimates (consensus)

MetricFY2026FY2027FY2028
Revenue$0.00$0.00$0.00
Net Income-$365.9M-$383.6M-$322.9M
EPS$-6.98$-7.28$-5.54
# Analysts (EPS)666